stories
 |
what we do
Dorsa takes pride in being the first producer of nitroglycerin in Iran and the MENA region. We offer a diverse selection of Nitroglycerin semi-finished materials in various concentrations and dosage forms. Our finished Nitroglycerin products, including tablets, capsules, and sprays, adhere to the latest international standards set by the Food and Drug Organization of the Ministry of Health. Contact us to learn more about our nitroglycerin offerings.
Notarkib Company (Recpharma) in Iran developed the first recombinant product, interferon-gamma 1b, followed by erythropoietin alpha. In 2019, the company merged with Dorsa Pharma to ensure the continued production and supply of sufficient quantities of the drug. Presently Dorsa is the only bio-similar producer of Interferon Gamma (Gammarec®) in the world which we export to several countries (Click here for more information on our bio-similar products).
Dorsa's solid dosage production lines are among the best accredited by the Iran FDA, complying with GMP of PIC/S and WHO guidelines. Our commitment to quality ensures that our generic drugs meet the highest standards. Contact us to explore our range of generic drugs.
Dorsa has expanded into the production of sports supplements in the pharmaceutical class, ensuring high quality at our free zone site. Our sports supplements can play a small but important role in the sports nutrition plans of high-performance athletes. Contact us to learn more about our sports supplement offerings. |